4//SEC Filing
MISHAN ORLY 4
Accession 0000899243-21-003665
CIK 0001805387other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:35 PM ET
Size
7.1 KB
Accession
0000899243-21-003665
Insider Transaction Report
Form 4
MISHAN ORLY
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-01-26−38,450→ 426,913 totalExercise: $3.50Exp: 2029-06-25→ Common Stock (38,450 underlying) - Exercise/Conversion
Common Stock
2021-01-26$3.50/sh+38,450$134,575→ 38,450 total
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on July 15, 2020, with remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001830911
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 7:35 PM ET
- Size
- 7.1 KB